"Inflammatory" breast cancer

M Cariati; T M nett-Britton; S E Pinder; A D Purushotham

doi:10.1016/j.suronc.2005.07.004

"Inflammatory" breast cancer

M Cariati, T M nett-Britton, S E Pinder, A D Purushotham

Comprehensive Cancer Centre

Research output: Contribution to journal › Literature review › peer-review

21 Citations (Scopus)

Abstract

BACKGROUND: "Inflammatory" breast cancer is a rare and very aggressive form of the disease characterised by rapid onset and dismal outcome. METHODS: This review describes the clinical and molecular aspects of inflammatory breast cancer. The relevant English language literature on of inflammatory breast cancer was searched via Medline and ISI Web of Knowledge Cross Search (1924-2005), cross-referencing with key articles on the subject. RESULTS AND CONCLUSION: An increasing body of evidence demonstrates that inflammatory breast cancer is a unique form of breast cancer. A prompt diagnosis and multidisciplinary approach (based on neoadjuvant chemotherapy, loco-regional treatment with surgery and/or radiotherapy, followed in some cases by adjuvant systemic therapy) are the two factors most likely to have an impact on survival. As the molecular basis of the disease is becoming increasingly more defined, new potential therapeutic targets may arise in the future

Original language	English
Pages (from-to)	133 - 143
Number of pages	11
Journal	Surgical Oncology
Volume	14
Issue number	3
DOIs	https://doi.org/10.1016/j.suronc.2005.07.004
Publication status	Published - Nov 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.suronc.2005.07.004

Cite this

@article{6e0728d87f644aba9f6d79279f2e5215,

title = "{"}Inflammatory{"} breast cancer",

abstract = "BACKGROUND: {"}Inflammatory{"} breast cancer is a rare and very aggressive form of the disease characterised by rapid onset and dismal outcome. METHODS: This review describes the clinical and molecular aspects of inflammatory breast cancer. The relevant English language literature on of inflammatory breast cancer was searched via Medline and ISI Web of Knowledge Cross Search (1924-2005), cross-referencing with key articles on the subject. RESULTS AND CONCLUSION: An increasing body of evidence demonstrates that inflammatory breast cancer is a unique form of breast cancer. A prompt diagnosis and multidisciplinary approach (based on neoadjuvant chemotherapy, loco-regional treatment with surgery and/or radiotherapy, followed in some cases by adjuvant systemic therapy) are the two factors most likely to have an impact on survival. As the molecular basis of the disease is becoming increasingly more defined, new potential therapeutic targets may arise in the future",

author = "M Cariati and nett-Britton, {T M} and Pinder, {S E} and Purushotham, {A D}",

year = "2005",

month = nov,

doi = "10.1016/j.suronc.2005.07.004",

language = "English",

volume = "14",

pages = "133 -- 143",

journal = "Surgical Oncology",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - "Inflammatory" breast cancer

AU - Cariati, M

AU - nett-Britton, T M

AU - Pinder, S E

AU - Purushotham, A D

PY - 2005/11

Y1 - 2005/11

N2 - BACKGROUND: "Inflammatory" breast cancer is a rare and very aggressive form of the disease characterised by rapid onset and dismal outcome. METHODS: This review describes the clinical and molecular aspects of inflammatory breast cancer. The relevant English language literature on of inflammatory breast cancer was searched via Medline and ISI Web of Knowledge Cross Search (1924-2005), cross-referencing with key articles on the subject. RESULTS AND CONCLUSION: An increasing body of evidence demonstrates that inflammatory breast cancer is a unique form of breast cancer. A prompt diagnosis and multidisciplinary approach (based on neoadjuvant chemotherapy, loco-regional treatment with surgery and/or radiotherapy, followed in some cases by adjuvant systemic therapy) are the two factors most likely to have an impact on survival. As the molecular basis of the disease is becoming increasingly more defined, new potential therapeutic targets may arise in the future

AB - BACKGROUND: "Inflammatory" breast cancer is a rare and very aggressive form of the disease characterised by rapid onset and dismal outcome. METHODS: This review describes the clinical and molecular aspects of inflammatory breast cancer. The relevant English language literature on of inflammatory breast cancer was searched via Medline and ISI Web of Knowledge Cross Search (1924-2005), cross-referencing with key articles on the subject. RESULTS AND CONCLUSION: An increasing body of evidence demonstrates that inflammatory breast cancer is a unique form of breast cancer. A prompt diagnosis and multidisciplinary approach (based on neoadjuvant chemotherapy, loco-regional treatment with surgery and/or radiotherapy, followed in some cases by adjuvant systemic therapy) are the two factors most likely to have an impact on survival. As the molecular basis of the disease is becoming increasingly more defined, new potential therapeutic targets may arise in the future

U2 - 10.1016/j.suronc.2005.07.004

DO - 10.1016/j.suronc.2005.07.004

M3 - Literature review

VL - 14

SP - 133

EP - 143

JO - Surgical Oncology

JF - Surgical Oncology

IS - 3

ER -

"Inflammatory" breast cancer

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this